Last Updated on Nov 13, 2026

Cancer Innovation- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details


Published By: John Wiley and Sons Inc

Abbreviation: Cancer Innov.




Impact Score

The impact Score or journal impact score (JIS) is equivalent to Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. On the other hand, Impact Score is based on Scopus data.

3.78

SJR

 0.921

h-Index

 13

Rank

 5573

Important Details

Title Cancer Innovation
Standard Abbreviation Cancer Innov.
Type of Publication Journal
Discipline Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Drug Discovery (Q2); Oncology (Q2); Pharmacology (medical) (Q2); Cancer Research (Q3)
Impact Score 3.78
SCImago Journal Rank (SJR) 0.921
h-index 13
Overall Rank 5573
Publisher Name John Wiley and Sons Inc
Publication Country United States
International Standard Serial Number (ISSN) 27709191, 27709183
Coverage and History 2022-2026
Best Quartile Q1
Total Citations Received
(Last 3 Year)
443

About Cancer Innovation


Cancer Innovation is a journal published by John Wiley and Sons Inc. This journal covers the area[s] related to Pharmacology, Toxicology and Pharmaceutics (miscellaneous), Drug Discovery, Oncology, Pharmacology (medical), Cancer Research, etc. The coverage history of this journal is as follows: 2022-2026. The rank of this journal is 5573. This journal's impact score, h-index, and SJR are 3.78, 13, and 0.921, respectively. The ISSN of this journal is/are as follows: 27709191, 27709183.

The best quartile of Cancer Innovation is Q1. This journal has received a total of 443 citations during the last three years (Preceding 2025).


Cancer Innovation Impact Score 2025-2026


The latest impact score (IS) of the Cancer Innovation is 3.78. It is computed in the year 2026 as per its definition and based on Scopus data. 3.78

It is increased by a factor of around 1.71, and the percentage change is 82.61% compared to the preceding year 2024, indicating a rising trend.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Prediction of Cancer Innovation Impact Score 2026


Impact Score 2025 of Cancer Innovation is 3.78. If a similar upward trend continues, IS may increase in 2026 as well.


Impact Score Graph


Check below the Impact Score trends of Cancer Innovation. This is based on Scopus data.


Year Impact Score (IS)
2026/2027 Coming Soon
2025 3.78
2024 2.07
2023 1.15

Cancer Innovation h-index


  Table Setting

The h-index of Cancer Innovation is 13. By definition of the h-index, this journal has at least 13 published articles with more than 13 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.




Cancer Innovation ISSN


The International Standard Serial Number (ISSN) of Cancer Innovation is/are as follows: 27709191, 27709183.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Table Setting

Cancer Innovation Ranking and SCImago Journal Rank (SJR)


The Cancer Innovation is ranked 5573 among 27955 Journals, Conferences, and Book Series. As per SJR, this journal is ranked 0.921.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Cancer Innovation Publisher


Table Setting

The publisher of Cancer Innovation is John Wiley and Sons Inc. The publishing house of this journal is located in the United States. Its coverage history is as follows: 2022-2026.


Call For Papers (CFPs)


Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).


Abbreviation


The International Organization for Standardization 4 (ISO 4) abbreviation of Cancer Innovation is Cancer Innov.. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).

As ISO 4 is an international standard, the abbreviation ('Cancer Innov.') can be used for citing, indexing, abstraction, and referencing purposes.


How to publish in Cancer Innovation


If your area of research or discipline is related to Pharmacology, Toxicology and Pharmaceutics (miscellaneous), Drug Discovery, Oncology, Pharmacology (medical), Cancer Research, etc., please check the journal's official website to understand the complete publication process.


Acceptance Rate


There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

  • Interest/demand of researchers/scientists for publishing in a specific journal/conference.
  • The complexity of the peer review process and timeline.
  • Time taken from draft submission to final publication.
  • Number of submissions received and acceptance slots
  • And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.



Frequently Asked Questions (FAQ)


What is the impact score of Cancer Innovation?

The latest impact score of Cancer Innovation is 3.78. It is computed in the year 2026.


What is the h-index of Cancer Innovation?

The latest h-index of Cancer Innovation is 13. It is evaluated in the year 2026.


What is the SCImago Journal Rank (SJR) of Cancer Innovation?

The latest SCImago Journal Rank (SJR) of Cancer Innovation is 0.921. It is calculated in the year 2026.


What is the ranking of Cancer Innovation?

The latest ranking of Cancer Innovation is 5573. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2026.


Who is the publisher of Cancer Innovation?

Cancer Innovation is published by John Wiley and Sons Inc. The publication country of this journal is United States.


What is the abbreviation of Cancer Innovation?

This standard abbreviation of Cancer Innovation is Cancer Innov..


Is "Cancer Innovation" a Journal, Conference or Book Series?

Cancer Innovation is a journal published by John Wiley and Sons Inc.


What is the scope of Cancer Innovation?

The scope of Cancer Innovation is as follows:

  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
  • Drug Discovery
  • Oncology
  • Pharmacology (medical)
  • Cancer Research

For detailed scope of Cancer Innovation, check the official website of this journal.


What is the ISSN of Cancer Innovation?

The International Standard Serial Number (ISSN) of Cancer Innovation is/are as follows: 27709191, 27709183.


What is the best quartile for Cancer Innovation?

The best quartile for Cancer Innovation is Q1.


What is the coverage history of Cancer Innovation?

The coverage history of Cancer Innovation is as follows 2022-2026.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/
  • Issn.org, https://www.issn.org/
  • Scopus, https://www.scopus.com/

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.


Impact Score, SJR, h-Index, and Other Important metrics of These Journals, Conferences, and Book Series


Journal/Conference/Book Title Type Publisher Ranking SJR h-index Impact Score
European Union Politics Journal SAGE Publications Ltd 2915 83 3.16
Historia Journal Universidade Estadual Paulista (UNESP) 19366 10 0.23
Journal of Field Archaeology Journal Maney Publishing 7503 50 1.36
Proceedings of the International Symposium on Power Semiconductor Devices and ICs Conference And Proceedings Institute of Electrical and Electronics Engineers Inc. 11458 57 1.86
Istanbul University - Journal of Electrical and Electronics Engineering Journal University of Istanbul 24654 0 0.00
Business Strategy Review Journal Wiley-Blackwell Publishing Ltd 31512 33 0.04
Journal of Classical Sociology Journal SAGE Publications Ltd 15585 34 0.84
Journal of Sociolinguistics Journal Wiley-Blackwell Publishing Ltd 6539 73 2.05
Biological Procedures Online Journal BioMed Central Ltd 5480 56 4.51
Journal des Professionnels de l'Enfance Journal TPMA 30098 2 0.00

Check complete list




Cancer Innovation Impact Score (IS) Trend

Table: Impact Score

Year Impact Score (IS)
2026/2027 Updated Soon
2025 3.78
2024 2.07
2023 1.15



Top Journals/Conferences in Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

PharmacoVigilance Review
Euromed Communications | United Kingdom

See All

Top Journals/Conferences in Drug Discovery

RSC Drug Discovery Series
Royal Society of Chemistry | United Kingdom

Open Access Journal of Medicinal and Aromatic Plants
Medicinal and Aromatic Plants Association of India | India

Drug Discovery World
RJ Communications and Media Ltd. | United Kingdom

Journal of Pharmaceutical Negative Results
Wolters Kluwer Medknow Publications | India

See All

Top Journals/Conferences in Oncology

Cancer Microenvironment
Springer Netherlands | Netherlands

Current Colorectal Cancer Reports
Springer Science + Business Media | United States

Australian Journal of Cancer Nursing
Cambridge Media | Australia

Clinical Sarcoma Research
BioMed Central Ltd. | United Kingdom

Onkologe
Springer Verlag | Germany

Onkopediatria
Paediatrician Publishers, LLC | Russian Federation

See All

Top Journals/Conferences in Pharmacology (medical)

Frontiers in Clinical Drug Research - Alzheimer Disorders
Bentham Science Publishers B.V. | Netherlands

P and T
MediMedia USA Inc. | United States

Journal of Population Therapeutics and Clinical Pharmacology
Dougmar Publishing Group Inc. | Canada

Pharmacien Hospitalier et Clinicien
Elsevier Masson s.r.l. | France

Clinical Pharmacist
Pharmaceutical Press | United Kingdom

Australian Journal of Pharmacy
Australian Pharmaceutical Publishing Company Ltd | Australia

Archivos Venezolanos de Farmacologia y Terapeutica
Sociedad Latinoamericana de Hipertension | Venezuela

See All

Top Journals/Conferences in Cancer Research

Cancer Microenvironment
Springer Netherlands | Netherlands

See All